Sterling Drug (Malaya) Sdn. Bhd. operates as part of the Pfizer group's historical and regional pharmaceutical structure. The company is engaged in the marketing, distribution, and regulatory management of pharmaceutical and healthcare products, including prescription medicines and consumer healthcare items. Its operations support healthcare providers, pharmacies, and institutional customers within Malaysia. Key assets include regulatory approvals, established product portfolios, and integration with global pharmaceutical manufacturing and research platforms. Strategically, the company is positioned to support public health needs through reliable supply, regulatory compliance, and alignment with international pharmaceutical standards.
Headquarters
Lot 89 Jalan Enggang, Ampang/Hulu Kelang Industrial Estate
Ampang; Selangor;
Postal Code: 68000
Contact Details: Purchase the Sterling Drug (Malaya) S/B report to view the information.
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service